#hereditarycancer
LightNews LightNews
lmg622.bsky.social
Dr Emil Lou, medical oncologist & specialist in gastrointestinal cancers at the University of Minnesota talks about all things, updates, & advances in #pancreaticcancer , including #BRCA & #PARP therapies @medscape.com

#hereditarycancer #pancchat #medsky #genetics #pancsm
Pancreatic Cancer Therapy: What Comes Next?
Dr Emil Lou breaks down what’s changing in pancreatic cancer care, including neoadjuvant chemotherapy, genomic testing, and why progress remains incremental.
www.medscape.com
January 19, 2026 at 8:24 PM
lmg622.bsky.social
A #vaccine to prevent #coloncancer. Proof-of-concept for strong immune response and safety via neoantigens given to people with mutations for #Lynchsyndrome.

#hereditarycancer #genetics #medsky #cancerresearch
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial - Nature Medicine
In a phase 1b/2 trial, an off-the-shelf vaccine using gorilla adenoviral and modified vaccinia Ankara vectors with over 200 mutated peptides known to be present in persons with mismatch-repair-deficie...
www.nature.com
January 19, 2026 at 8:19 PM
lmg622.bsky.social
This review provides a comprehensive overview of #hereditarycancer predisposing to breast and gynecologic malignancies, with a focus on genetic basis, associated cancer risks, and implications for clinical management.

#bcsm #gyncsm #genetics #womenshealth #cancerresearch #medsky
Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications - Archives of Gynecology and Obstetrics
A relevant proportion of malignancies predominantly or exclusively affecting women, including breast and gynecologic cancers, is attributable to hereditary tumor syndromes, profoundly impacting cancer...
link.springer.com
January 18, 2026 at 5:35 PM
insight-org.bsky.social
Save the Date! Join us for the first Y-InSiGHT webinar on career development for emerging professionals in hereditary GI tumours.

📅 28 January | 🕒 14:00 CET | 💻 Online

Register now and find more info 👉 shorturl.at/k773K

#YInSiGHT #HereditaryCancer #Genetics #GIOncology #EarlyCareerResearchers
January 15, 2026 at 8:53 AM
ancan501c3.bsky.social
#brca #hereditarycancer #genetics #patientexperience
#EarlyDetection #her2 #prostatecancer #breastcancer #cysticfibrosis #sicklecell #heartdisease #diabetes #pancreaticcancer
January 8, 2026 at 6:05 PM
lmg622.bsky.social
The Angelina Jolie Effect: A Lasting Global Impact on #BRCA #HereditaryCancer Prevention. @oncodaily.bsky.social

#bcsm #gyncsm #genetics #womenshealth #medsky #patientexperience
The Angelina Jolie Effect: A Lasting Global Impact on Cancer Prevention - OncoDaily
“Angelina Jolie effect”: a measurable, sustained increase in genetic testing, cancer screening, and awareness worldwide.
oncodaily.com
December 22, 2025 at 10:20 PM
lmg622.bsky.social
No Increased #BreastCancer Risk With Menopausal Estrogen in #BRCA Carriers: Estrogen-only #HRT tied to significantly lower risk, no adverse effect of combined hormones.

Via @medpagetoday.com

#SABCS #hereditarycancer #womenshealth #bcsm #cancerresearch #medsky
No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers
Estrogen-only HRT tied to significantly lower risk, no adverse effect of combined hormones
www.medpagetoday.com
December 15, 2025 at 3:59 PM
brcaresponder.bsky.social
The male breast cancer story of former San Diego Chargers defensive tackle, Tony Savage via My Faulty Gene.
Watch here: familygeneshare.org/T3140

#FamilyGeneShare #BRCA #ItsNotJustPink #MaleBreastCancer #SanDiegoChargers #MustWatch #HereditaryCancer #MensHealth
December 7, 2025 at 7:31 PM
dnatodaypodcast.bsky.social
Virtual tools are breaking down barriers to #genetictesting 📱💻

Myriad Genetics’ new study shows that #digitaleducation & at-home risk assessment significantly boost participation in #hereditarycancer screening.
Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology
Myriad Genetics announced a hereditary cancer risk assessment program study was published in Obstetrics & Gynecology (also known as The Green Journal)....
www.globenewswire.com
November 30, 2025 at 6:30 PM
lmg622.bsky.social
First steps towards a targeted #prostatecancer screening programme in the UK: If implemented, the proposal will invite men aged 45 - 61 with a mutation in the #BRCA genes for PC screenings every 2 years.

Via @cancerresearchuk.org

#hereditarycancer #genetics #menshealth #medsky #cancerresearch
First steps towards a targeted prostate cancer screening programme - Cancer Research UK - Cancer News
The UK NSC's proposed screening programme would invite 45 to 61-year-old men with BRCA mutations for a PSA test every two years.
news.cancerresearchuk.org
November 28, 2025 at 11:50 PM
lmg622.bsky.social
A 13-year survivor of Stage 4 #pancreaticcancer, Steve Merlin now travels the world & mentors other patients with the same diagnosis. His mother had died of #breastcancer, & he inherited her faulty #BRCA gene.

#hereditarycancer #genetics #PARP #patientexperience #pancsm #medsky #cancerresearch
Is pancreatic cancer a death sentence? Interlaken man shares his story to spread hope
Steve Merlin works with fellow pancreatic cancer patients, telling his remarkable story of surviving 13 years since his diagnosis.
www.app.com
November 26, 2025 at 10:27 PM
dnatodaypodcast.bsky.social
Variants of uncertain significance are a pain. 🧩 Mayo Clinic researchers have made major strides recently classifying 91% of previously unknown #BRCA2 variants, bringing clarity to #hereditarycancer risk. A huge win for patients & #geneticcounselors.
Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care - Mayo Clinic Comprehensive Cancer Center Blog
Findings will help identify patients with breast, ovarian, pancreatic or prostate cancer who may benefit from targeted therapies.
cancerblog.mayoclinic.org
November 25, 2025 at 2:30 PM
lmg622.bsky.social
Talazoparib Benefits #BRCA Mutant Metastatic #BreastCancer & #OvarianCancer

#bcsm #gyncsm #genetics #hereditarycancer #medsky #cancerresearch #womenshealth
Talazoparib Benefits BRCA Mutant Metastatic Cancer
A recent multicenter retrospective study has cast new light on the therapeutic potential of talazoparib, a potent PARP inhibitor, in patients with BRCA-mutant metastatic breast and ovarian cancers.
bioengineer.org
November 24, 2025 at 5:13 AM
brcaresponder.bsky.social
thebrcaresponder.blogspot.com/2025/11/focu...
#BRCA #hereditarycancer #blogpost Hormone Replacement Therapy - HRT #HRT
Focus on HRT
Why I’m Excited HRT Is Finally Getting Attention  Author Georgia Hurst  Georgia Hurst is a fierce patient advocate for those with Lynch syn...
thebrcaresponder.blogspot.com
November 22, 2025 at 9:27 PM
dnatodaypodcast.bsky.social
November 17th is #WorldPancreaticCancerDay💜

Listen to #patientadvocate Dan Shockley’s personal #genetictesting journey with #hereditarycancer in this #sciencepodcast episode
#291 AFAP with Advocate Dan Dry Dock Shockley — DNA Today
A retired Navy veteran shares his experience of living with attenuated familial adenomatous polyposis (AFAP).
dnapodcast.com
November 17, 2025 at 2:45 PM
lmg622.bsky.social
In a groundbreaking study poised to transform our understanding of #hereditarycancer risks, researchers have unveiled new insights into differential impacts of #BRCA1 gene founder variants on contralateral #breastcancer & #ovariancancer among affected women.

#bcsm #gyncsm #genetics #cancerreseach
BRCA1 Variants: Contralateral vs Ovarian Cancer Risk
In a groundbreaking study poised to transform our understanding of genetic cancer risks, researchers have unveiled new insights into the differential impacts of BRCA1 gene founder variants on
bioengineer.org
November 16, 2025 at 8:20 PM
lmg622.bsky.social
Treatment of #infertility & risk of #breastcancer among women with a #BRCA pathogenic variant: An international matched case-control study.

#bcsm #hereditarycancer #womenshealth #genetics #camcerresearch #medsky
Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study - BMC Cancer
Background The global trend toward delayed childbearing has led to an increased use of fertility treatment, including in vitro fertilization (IVF) and hormonal medications. Concerns regarding the pote...
bmccancer.biomedcentral.com
November 11, 2025 at 10:13 PM
lmg622.bsky.social
Early #breastcancer in young #BRCA carriers from diagnosis to treatment and survivorship.

#bcsm #hereditarycancer #womenshealth #genetics #cancerresearch #medsky
Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship - Roberto Borea, Luca Arecco, Simone Nardin, Edoardo Chiappe, Chiara Lanzavecchia, Mónica Fragío Gil, Arianna M...
Breast cancer is the most frequent malignancy among young women, with unique challenges particularly for carriers of BRCA pathogenic or likely pathogenic varian...
journals.sagepub.com
November 10, 2025 at 4:56 PM
lmg622.bsky.social
#BRCA testing & subsequent treatment with #olaparib results in ⬇️ recurrences in early BC & ⬆️ life expectancy vs no testing & no treatment, suggesting there is substantial clinical value in widespread testing for this population.

#bcsm #hereditarycancer #PARP #cancerresearch #medsky #womenshealth
The estimated long-term clinical effects of BRCA testing and olaparib treatment of early breast cancer in the US population: a population impact model
Olaparib is approved for the treatment of germline BRCA mutant (gBRCAm) high-risk early breast cancer (eBC) following treatment with neoadjuvant or adjuvant chemotherapy. The potential long-term ou...
www.tandfonline.com
November 10, 2025 at 4:37 PM
lmg622.bsky.social
Asking For a Friend: How I Found Strength While Facing #BRCA related #BreastCancer — Twice

#hereditarycancer #bcsm #patientexperience #womenshealth #genetics #medsky
Asking For a Friend: How I Found Strength While Facing Breast Cancer — Twice
How I Found Strength While Facing Breast Cancer — Twice
www.theskimm.com
November 7, 2025 at 1:26 AM
lmg622.bsky.social
Navigating #menopause with faulty #BRCA gene: Testosterone’s potential in menopause care.

#hereditarycancer #gyncsm #womenshealth #QOL #bcsm #medsky
Navigating menopause with BRCA: Testosterone’s potential in menopause care | Contemporary OB/GYN
Explore innovative menopause management strategies for BRCA carriers, including testosterone therapy, to alleviate symptoms and enhance quality of life.
www.contemporaryobgyn.net
November 4, 2025 at 2:24 AM
celiadr.bsky.social
Please participate in this survey about the role of nurses in hereditary cancer care. It's the last week and we are still missing a few answers for the Study to be representative.

#CancerNursing #OncologyNurses #precisionOncology #PersonalisedCare #HereditaryCancer #brca #lynch
October 28, 2025 at 8:59 PM
lmg622.bsky.social
Assessment of barriers to #pancreaticcancer surveillance in high‐risk individuals @pennmedicine.bsky.social

#hereditarycancer #genetics #BRCA #medsky
Assessment of barriers to pancreatic cancer surveillance in high‐risk individuals
Individuals with increased familial or genetic risk of pancreatic cancer (PC) may be recommended to undergo regular PC surveillance. Genetic counselors are often involved in discussions about PC surveillance for high‐risk individuals (HRIs); ...
pmc.ncbi.nlm.nih.gov
October 28, 2025 at 5:35 AM
genes2go.bsky.social
#genechat #lynchsyndrome
#hereditarycancer
Finding Credible Voices in the Lynch Syndrome Community | CURE
When you’re living with a hereditary cancer syndrome, where you get your information matters just as much as the information itself.
www.curetoday.com
October 26, 2025 at 11:28 AM
lmg622.bsky.social
NRF2 and Estrogen Roles in #BRCA1 #BreastCancer
Via @bioengineer.org

#bcsm #hereditarycancer #womenshealth #genetics #cancerresearch #medsky
NRF2 and Estrogen Roles in BRCA1 Breast Cancer
Breast cancer remains the most frequently diagnosed malignancy among women worldwide, posing a significant threat to public health despite ongoing advances in detection and treatment. Approximately 5
bioengineer.org
October 24, 2025 at 4:46 PM